Oral Administration of an Apo A-I Mimetic Peptide Synthesized From D-Amino Acids Dramatically Reduces Atherosclerosis in Mice Independent of Plasma Cholesterol
- 22 January 2002
- journal article
- other
- Published by Wolters Kluwer Health in Circulation
- Vol. 105 (3), 290-292
- https://doi.org/10.1161/hc0302.103711
Abstract
When apolipoprotein A-I mimetic peptides synthesized from either D- or L-amino acids were given orally to LDL receptor-null mice, only the peptide synthesized from D-amino acids was stable in the c...Keywords
This publication has 7 references indexed in Scilit:
- A cell-free assay for detecting HDL that is dysfunctional in preventing the formation of or inactivating oxidized phospholipidsJournal of Lipid Research, 2001
- Effects of increasing hydrophobicity on the physical-chemical and biological properties of a class A amphipathic helical peptideJournal of Lipid Research, 2001
- A new synthetic class A amphipathic peptide analogue protects mice from diet-induced atherosclerosisJournal of Lipid Research, 2001
- Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: step 1Journal of Lipid Research, 2000
- Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: steps 2 and 3Journal of Lipid Research, 2000
- Human apolipoprotein A-I gene expression increases high density lipoprotein and suppresses atherosclerosis in the apolipoprotein E-deficient mouse.Proceedings of the National Academy of Sciences, 1994
- Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit.Journal of Clinical Investigation, 1990